Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Phase II PANTHEON results for neladenoson bialanate in heart failure patients reported

Aug. 30, 2018

AZD-5718: an oral FLAP inhibitor for the treatment of CAD

Aug. 29, 2018

BAY-1753011 provides vascular protection and decongestion without RAAS stimulation

Aug. 28, 2018

Xarelto receives approval in the E.U. for the treatment of patients with artery disease

Aug. 27, 2018

Amgen targets the apelin receptor with AMG-986 for heart failure therapy

Aug. 24, 2018

Berlin Cures completes phase I study of BC-007 for cardiomyopathy

Aug. 22, 2018

New oral selective apelin agonist AM-2995 developed for heart disease treatment

Aug. 21, 2018

Resverlogix announces seventh positive recommendation for phase III study of apabetalone

Aug. 8, 2018

Blood protein networks linked to complex diseases

Aug. 8, 2018

Study uncovers atrial fibrillation risk variants

Aug. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...